Aeris Therapeutics is a medical technology company dedicated to advancing solutions to diseases and conditions of the pulmonary system. It's lead product is the AeriSeal System, a treatment for advanced emphysema. The product is approved in Europe (CE mark) and Israel. The company is conducting a pivotal study of the product for US registration.
View Top Employees from Aeris TherapeuticsWebsite | http://www.aerist.com |
Revenue | $10.6 million |
Employees | 7 (7 on RocketReach) |
Founded | 2000 |
Phone | (702) 761-6846 |
Industry | Medical Devices, Medical Devices & Equipment, Biotechnology, Manufacturing, Science and Engineering |
SIC | SIC Code 384 Companies, SIC Code 38 Companies |
Looking for a particular Aeris Therapeutics employee's phone or email?
The Aeris Therapeutics annual revenue was $10.6 million in 2023.
7 people are employed at Aeris Therapeutics.
Aeris Therapeutics is based in Foxboro, Massachusetts.
The SIC codes for Aeris Therapeutics are [384, 38].